These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

GlobalData’s analysis starts in the year the FDA expanded the Jardiance label. Back then ... s stem cell therapy Revascor and Bayer’s Kerendia as other promising prospects.

expanding labels, and advancing late-stage assets," alluding to the new Kerendia and Nubeqa trials, as well as new menopause symptom treatment elinzanetant and acoramidis for ATTR cardiomyopathy ...

The data will be filed with regulatory authorities to seek an expansion of the label for Nubeqa, according to Bayer, which developed Nubeqa in collaboration with Finland's Orion. The drug is ...

The Food and Drug Administration announced a new proposal Tuesday that would require food and drink manufacturers to place ...

The U.S. Food and Drug Administration (FDA) is demanding increased, in-your-face food transparency when it comes to nutrition ...

The US Food and Drug Administration is proposing nutrition information be placed on the front of packaged foods to provide at ...

ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...

The Food and Drug Administration wants to change how packaged food is sold in the U.S. In the waning days of the Biden ...

The U.S. Food and Drug Administration (FDA) has proposed a new rule requiring bold, easy-to-read nutrition labels on the ...

Initially approved in 2019 for use alongside oral antidepressants, this label expansion follows a priority review from the FDA. The approval was based on data from the Phase IV TRD4005 study ...